Trademark: 90265504
Status Date
Monday, July 31, 2023
Filing Date
Tuesday, October 20, 2020
Published for Opposition
Tuesday, May 4, 2021
Abandoned Date
Monday, July 31, 2023
42 Development of pharmaceutical preparations for gene therapy; development of platform technology, namely, gene therapy platforms for manufacturing therapeutics; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Jul 31, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 31, 2023
Abandonment - No Use Statement Filed
Mar 10, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 10, 2023
Teas Change Of Correspondence Received
Mar 10, 2023
Teas Change Of Owner Address Received
Dec 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2022
Sou Extension 3 Granted
Dec 16, 2022
Sou Extension 3 Filed
Dec 16, 2022
Teas Extension Received
Jun 2, 2022
Notice Of Approval Of Extension Request E-Mailed
May 31, 2022
Sou Extension 2 Granted
May 31, 2022
Sou Extension 2 Filed
May 31, 2022
Teas Extension Received
Dec 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2021
Sou Extension 1 Granted
Dec 17, 2021
Sou Extension 1 Filed
Dec 17, 2021
Teas Extension Received
Jun 29, 2021
Noa E-Mailed - Sou Required From Applicant
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 26, 2021
Approved For Pub - Principal Register
Mar 20, 2021
Assigned To Examiner
Dec 8, 2020
New Application Office Supplied Data Entered
Oct 23, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
